title: Ruxolitinib Enhances Platelet Production in Patients With Thrombocytopenic Myelofibrosis.
authors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
authors: Michael R
authors: MR
authors: Grunwald
authors: Johns Hopkins University School of Medicine, Baltimore, MD jlspivak@jhmi.edu.
authors: Jerry L
authors: JL
authors: Spivak
mesh_terms: D001792:Blood Platelets / Q000502:physiology*; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors* / Q000235:genetics; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D009570:Nitriles; D011087:Polycythemia Vera / Q000188:drug therapy* / Q000473:pathology; D055728:Primary Myelofibrosis / Q000188:drug therapy* / Q000473:pathology; D011379:Prognosis; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000473:pathology
chemical_list: D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; C507924:JAK2 protein, human; D053614:Janus Kinase 2